tiprankstipranks
American Oncology Network (AONC)
OTHER OTC:AONC
US Market
AONC
American Oncology Network
RESEARCH TOOLSreports
Want to see AONC full AI Analyst Report?

American Oncology Network (AONC) Ratios

42 Followers

American Oncology Network Ratios

AONC's free cash flow for Q4 2024 was $0.09. For the 2024 fiscal year, AONC's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.53 1.53 1.64 1.72 1.75
Quick Ratio
 1.25 1.25 1.38 1.46 1.46
Cash Ratio
 0.29 0.29 0.17 0.19 0.23
Solvency Ratio
 0.04 0.04 0.04 0.07 0.27
Operating Cash Flow Ratio
 -0.02 -0.02 -0.11 -0.05 -0.22
Short-Term Operating Cash Flow Coverage
 -1.32 -1.32 -2.30 -0.71 0.00
Net Current Asset Value
$ -30.85M$ -30.85M$ -25.94M$ -22.19M$ 186.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.31 0.34 0.39 0.26
Debt-to-Equity Ratio
 7.85 7.85 -0.79 2.05 0.20
Debt-to-Capital Ratio
 0.89 0.89 -3.84 0.67 0.17
Long-Term Debt-to-Capital Ratio
 0.82 0.82 -0.99 0.56 0.17
Financial Leverage Ratio
 25.06 25.06 -2.32 5.26 0.79
Debt Service Coverage Ratio
 -0.06 -0.06 -2.78 1.77 5.21
Interest Coverage Ratio
 -2.47 -2.47 -7.66 1.63 0.64
Debt to Market Cap
 0.35 1.31 2.24 0.21 0.16
Interest Debt Per Share
 11.26 11.26 20.15 3.13 1.56
Net Debt to EBITDA
 46.57 46.57 -2.54 4.34 4.63
Profitability Margins
Gross Profit Margin
6.70%6.70%6.47%8.30%8.26%
EBIT Margin
-1.00%-1.00%-4.38%0.52%0.19%
EBITDA Margin
0.10%0.10%-3.08%2.01%0.83%
Operating Profit Margin
-0.99%-0.99%-3.84%0.48%0.10%
Pretax Profit Margin
-1.39%-1.39%-4.89%0.23%0.04%
Net Profit Margin
-0.23%-0.23%-0.43%0.23%-0.01%
Continuous Operations Profit Margin
-1.53%-1.53%-4.92%0.23%-0.01%
Net Income Per EBT
16.24%16.24%8.87%100.00%-29.58%
EBT Per EBIT
140.34%140.34%127.17%46.51%38.97%
Return on Assets (ROA)
-0.84%-0.84%-1.48%0.79%-0.04%
Return on Equity (ROE)
5.56%-21.17%3.43%4.17%-0.03%
Return on Capital Employed (ROCE)
-6.88%-6.88%-23.93%3.00%0.71%
Return on Invested Capital (ROIC)
-6.56%-6.56%-22.22%2.72%-0.21%
Return on Tangible Assets
-0.87%-0.87%-1.48%0.80%-0.04%
Earnings Yield
-3.22%-5.72%-14.05%0.62%-0.03%
Efficiency Ratios
Receivables Turnover
 9.28 9.28 7.75 6.92 6.83
Payables Turnover
 9.62 9.62 9.37 9.90 9.32
Inventory Turnover
 27.04 27.04 26.84 28.90 25.07
Fixed Asset Turnover
 17.86 17.86 15.27 15.19 28.91
Asset Turnover
 3.74 3.74 3.42 3.52 3.80
Working Capital Turnover Ratio
 15.75 15.75 12.19 12.10 21.22
Cash Conversion Cycle
 14.87 14.87 21.74 28.49 28.81
Days of Sales Outstanding
 39.34 39.34 47.09 52.73 53.42
Days of Inventory Outstanding
 13.50 13.50 13.60 12.63 14.56
Days of Payables Outstanding
 37.96 37.96 38.94 36.87 39.17
Operating Cycle
 52.84 52.84 60.69 65.36 67.97
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.36 -0.36 -2.71 -0.16 -0.63
Free Cash Flow Per Share
 -1.89 -1.89 -4.55 -0.34 -0.83
CapEx Per Share
 1.53 1.53 1.84 0.17 0.20
Free Cash Flow to Operating Cash Flow
 5.24 5.24 1.68 2.06 1.32
Dividend Paid and CapEx Coverage Ratio
 -0.24 -0.24 -1.48 -0.94 -3.16
Capital Expenditure Coverage Ratio
 -0.24 -0.24 -1.48 -0.94 -3.16
Operating Cash Flow Coverage Ratio
 -0.03 -0.03 -0.14 -0.05 -0.41
Operating Cash Flow to Sales Ratio
 >-0.01 >-0.01 -0.01 >-0.01 -0.03
Free Cash Flow Yield
-9.84%-37.31%-77.07%-3.34%-8.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -31.07 -17.47 -7.12 161.82 -3.87K
Price-to-Sales (P/S) Ratio
 0.15 0.04 0.03 0.36 0.43
Price-to-Book (P/B) Ratio
 6.58 3.70 -0.24 6.76 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.16 -2.68 -1.30 -29.98 -11.73
Price-to-Operating Cash Flow Ratio
 -24.98 -14.04 -2.18 -61.76 -15.43
Price-to-Earnings Growth (PEG) Ratio
 0.47 0.35 <0.01 -0.06 38.58
Price-to-Fair Value
 6.58 3.70 -0.24 6.76 1.30
Enterprise Value Multiple
 191.60 84.81 -3.54 22.49 56.39
Enterprise Value
 347.75M 153.93M 139.23M 519.17M 442.80M
EV to EBITDA
 191.60 84.81 -3.54 22.49 56.39
EV to Sales
 0.20 0.09 0.11 0.45 0.47
EV to Free Cash Flow
 -13.43 -5.94 -4.58 -37.14 -12.78
EV to Operating Cash Flow
 -70.35 -31.14 -7.68 -76.53 -16.81
Tangible Book Value Per Share
 6.90 6.90 10.39 1.46 5.40
Shareholders’ Equity Per Share
 1.37 1.37 -24.19 1.49 7.50
Tax and Other Ratios
Effective Tax Rate
 -0.10 -0.10 >-0.01 0.00 1.30
Revenue Per Share
 128.27 128.27 191.32 27.58 22.64
Net Income Per Share
 -0.29 -0.29 -0.83 0.06 >-0.01
Tax Burden
 0.16 0.16 0.09 1.00 -0.30
Interest Burden
 1.39 1.39 1.11 0.43 0.20
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.08 0.08 0.08 0.08 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 0.00 <0.01
Income Quality
 0.18 0.18 0.29 -2.62 250.84
Currency in USD